secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001459839-25-000059
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q1 revenue up 25% to $47.3M, posts positive adjusted EBITDA, raises FY guidance
--------------------------------------------------------------------------------

- Worldwide revenue $47.3M, up 24.9% YoY; U.S. revenue $44.8M, up 26.6%.
- Gross margin 79.7% vs 78.9% a year ago; net loss improved 40% to $6.5M ($0.15/share).
- Adjusted EBITDA positive $0.5M vs loss of $4.0M in Q1 2024; cash $144.4M, net cash usage down 31.7%.
- FY2025 revenue guidance raised to $193.5M-$197.5M (prior $193.5M-$195.5M); expects positive adjusted EBITDA for full year.
- Added 300 active U.S. physicians in Q1; CMS proposed NTAP for iFuse TORQ TNT up to $3,960/ procedure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/0001459839-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/sibn-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001459839-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer